A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC)

NCT03678480 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Corporate decision

Conditions

Primary Sclerosing Cholangitis
Cholangitis
Cholangitis, Sclerosing
Bile Duct Diseases
Biliary Tract Diseases
Digestive System Diseases
Adolescent

Interventions

DRUG: HTD1801
DRUG: Ursodeoxycholic Acid

Sponsor

HighTide Biopharma Pty Ltd